Inderesin vastuuvapauslauseke löytyy täältä. Kunkin Inderesin aktiivisessa seurannassa olevan osakkeen tarkemmat tiedot löytyvät kunkin osakkeen omilta yhtiösivuilta Inderes-sivustolla. © Inderes Oyj. Kaikki oikeudet pidätetään.
Lue webcast- ja audiocast-lähetysten transkriptejä
Lue webcast- ja audiocast-lähetysten transkriptejä
Huomio: Tämä on koneellisesti luotu transkripti ja se saattaa sisältää epätarkkuuksia.
Hello everyone, and welcome to the Solar Foods go-to-market update. My name is Maria and I'm here today with our CEO, Rami Jokela, and CFO and Deputy CEO, Ilkka Saura. Also with us today is Heli Anttila from Fazer, Vice President, Product Research and Development. It has been an exciting day for Solar Foods. We will first talk about the new chapter about to begin for Solein in Europe. We will present a market update and discuss our go-to-market strategy, and Heli will be talking about Fazer's plans for commercializing Solein. You in the audience have the possibility to ask questions in the chat function throughout the webcast, and at the end of the presentation, we will have a Q&A session. Let's get going. Rami, please.
Yeah. Thank you, Maria. This is absolutely the day. What we have been waiting for for a long time. So, what has happened? The news today represents a significant milestone in Solar Foods' whole history. The European Food Safety Authority, EFSA, has completed its scientific safety assessment positively and concluded that Solein, our product, is safe under the proposed conditions of use. This is absolutely great news. You can feel it perhaps from me already, how excited I am. But we have been waiting for this for a long time. And this is not only good news for Solar Foods, but especially for customers and consumers in Europe. EFSA is the gold standard. EFSA's scientific assessment is widely regarded as one of the most extensive and thorough food safety reviews globally. The positive opinion that we have now achieved can therefore provide a strong reference point for other markets, especially where an equivalent novel food assessment framework may not exist today. We are absolutely happy with this as a reference point as well. The assessment itself took quite a long time. We started with our application in 2021, already five years ago. But we are very happy because EFSA has conducted an extensive scientific safety assessment covering the product manufacturing process and consumer safety, supported by our detailed information and scientific evidence. What we have provided in the good collaboration. So we are very happy, even if it took a very long time, as it is the gold standard. And now we have achieved this positive opinion. So let's celebrate a little bit when it's really the time. But now, what is the next step? Next step. The European Commission will now prepare the draft implementing act, present it to the relevant members of the Standing Committee for a vote, and formally adopt the act. We estimate that this process will take approximately 7 to 9 months based on similar novel food ingredient EU authorization. We. At Solar Foods, we are very confident that the vote result will support EFSA's positive scientific opinion, which was published today. There is also another reason why today is a significant day for Solar Foods. We are the first company in the world to receive the positive EFSA opinion for the novel food ingredient produced through gas fermentation technology. Why is that? Gas fermentation technology enables the production of large volumes of food in the most economic and cost-efficient way. Compared to any other fermentation technologies. So we see that this could enable the production of huge volumes of food proteins at affordable prices for consumers. So let's look at what EFSA's positive opinion really means to us now. So what will change? So after the EFSA's positive scientific opinion, we expect EU authorisation next year in 2025. The process will take, as I said, 7 to 9 months based on our estimation. This will continue to accelerate all our commercial negotiations in Europe already, because everybody has been waiting for this scientific opinion, which is positive, and for all the launch plans that are coming. Typically, it also takes a long time. So I really see that this will accelerate all these negotiations and discussions regarding which countries, which companies, and which products we are going to launch. The scientific opinion is also absolutely key for binding offtake negotiations for the factory. Factory 02. And this is going to continue and accelerate. Many of our customers have been waiting for this one. This is a key milestone, really, to continue the negotiations as well as to accelerate many more. This is also doubling our addressable market. If we combine the US, where we have actually been for some time, as well as Singapore. But now Europe is one of the major markets. So we are doubling our addressable market. Now, what Ilkka Saura will tell you more about, and this is also our home market. Of course, we want to be present in our home market. Our consumers can enjoy the Solein-based products. So finally, if I put what is the key for especially me as a CEO, the key uncertainty regarding the Factory 02 financing plans and also the offtake agreements which are linked with that, they are absolutely reduced. So this risk, regarding what might happen, is significantly reduced. So it has absolutely reduced this uncertainty. And this is very good, as it supports our operations. Now for our final investment decisions. Path towards the Factory 02. One point regarding why the Solein demand, and demand in general, is so significant. We have already explained the protein megatrend in our half-year updates, just as we did in our H1 update a few months back. McKinsey has now updated their figures on the consumer wellness market. And it is already 2.7 trillion USD. It is more than 20% higher than it was two years ago. Really, it is accelerating. There seems to be more momentum and more demand coming as well. There is a challenge in the supply of high-quality proteins. And why is that? Consumers are seeking healthier lifestyles. And they are really looking at the ingredient list of the proteins. What about complete proteins? Those are proteins that will be everywhere. Every food category, breakfast, coffee, and all these other areas as well. What was typically, perhaps in the past, only for sports people. And then the third one. It's also the weight loss drugs driving the demand. GLP-1 users are typically doubling their protein intake daily as well. So typically, a normal person consumes a little bit less than one gram per kilo per day. So it can go up to 1.6g per kilo per day if you are a GLP-1 user. In order to have quality protein and support all your body systems, muscles, and so on. That is the big picture. As CEO of Solar Foods, I see this as a significant day to think about how we can help Europe and the rest of the world. Because EFSA is the gold standard. As I said, the United Nations has indicated that we need 60% more food production to feed the world's population by 2050. At the same time, the United Nations has indicated that there will be 25% less food production due to climate change, water scarcity, and soil degradation. So you can see that there is a mismatch. More is needed, while at the same time less will be available. And why is that? Global warming is affecting food prices, agricultural land, and availability. Already, 43% of land is used for agriculture. There is no more arable land available in the world for that purpose. El Niño this year has absolutely affected food prices, and we will see this impact over the next two years. It can be up to a 16% increase in ingredient prices. This is the highest ever impact. What we have understood in the past is that fertilizer prices have instability. So. We have seen that some of those prices have doubled. And perhaps very interestingly, there is also a decrease in dairy production output because of the extreme heat conditions, and because those will affect the milk yield from the cows. That is why many countries and regions are looking for this food sovereignty. They are seeing how we can actually have stable, affordable prices, quality, and supply at Solar Foods. We have been contacted by more than 40 different countries looking to establish factories to support food security or food sovereignty. And of course, this is absolutely because of what I said: there is a greater need for food, and there is expected to be less food production during this climate change. Water scarcity and soil degradation. All right. Next, we move to our go-to-market update. I would like to tell you a little bit more. I would like to explain how we have been working with our customers in the past. We have set up a core team to lead all negotiations with our key customers. The market launch has been led by me, our CCO. Zijlstra, and also our CFO and Deputy CEO, Ilkka Saura. We have been a team of three, supported by all the commercial product and regulatory personnel. We have been working with our customers continuously to determine how we can translate our value proposition into working application development, end-to-end launch plans, and the associated offtake agreements and terms. That is why, with the latest news as well, you, as Deputy CEO, are taking care of our company's entire commercial traction. So I am very happy to hand over to you to tell us about the market and what this means from a commercial point of view for Solar Foods. Thank you so much.
I am Ilkka Saura, CFO and Deputy CEO of the company. Very pleased to be here with you today and taking an overview on the markets. This indeed adds a significant new element to the addressable market. We are also taking a look at what is happening in the markets and what our go-to-market strategy is as we move on with the commercialization of Solein. We are very glad to discuss the EU market, our home turf, which is now opening for us through this EFSA scientific opinion, with the final approval looming on the horizon, but also a wider view of what is happening. So indeed, we are seeing a major market shift. Protein is no longer just a high-end sports nutrition ingredient; it is becoming mainstream and moving into everyday foods. It is now a staple on all of our plates. And our focus is indeed in this larger addressable market, solving traditional protein challenges which are gaining more ground, as well as meeting these demand drivers, which are somewhat interesting as we speak and providing us quite a bit of tailwind. The core theme around these markets and these functional foods, which we introduced today, is nutrient density. It's not only about protein; it's also about fibers and other nutritional values in which Solein indeed excels quite a bit. It is. So let's take a view on how the addressable market is developing. As I mentioned. Indeed, we see a structural shift in nutrition which is impacted by a number of drivers. Also, Rami explained that people are seeking and shifting towards active lifestyles. They discuss healthy aging and better metabolic health, meaning that global protein demand is growing, protein is moving into mainstream foods and applications requiring more taste and functionality than before, and consumers are not willing to compromise. Solein as an ingredient, and with its inherent characteristics, is becoming increasingly relevant from a commercial angle because of its superior characteristics in taste, texture, nutritional values, and so forth. We have opened a new category as part of the market called functional foods. We originally looked at Solein primarily through the lens of the high-performance sports nutrition market. What we now see is much broader. Protein is becoming an everyday consumer benefit that significantly expands the number of applications where Solein can add value. The European Union market is indeed a key priority for us. It represents a significant commercial opportunity for Solar Foods alongside the United States, where the company has already been commercializing Solein for two years, and where we also have quite nice results. The total addressable market for Solein in the European Union is expected to hit €7 billion by 2030. It is the second-largest protein market in the world in terms of the numbers. By 2030. This combined addressable market will reach around €18 billion, of which Europe itself accounts for about €7 billion, meaning about an 8% compound annual growth rate from 2025 to 2030. So, it is an absolutely interesting market, and our focus in this market will remain on strategic categories in the premium segments, as well as customers and partnerships that focus on functionality and differentiation, which matter the most to our customers. Solein is now deemed safe in Europe. It indeed provides steady supply, consistent quality, and predictable economics for our customers. These are the key building blocks for the success in the combined market, which I just presented. Controlled production supports consistent year-round output, providing the customers the opportunity to base their business models and growth projections on this. In this business, value propositions remain superior. Nutritional values, functionality, resilience, and sustainability remain at the core of this ingredient. And what is happening in the markets at the moment? And while we benchmark ourselves, we typically take the benchmark whey animal-based protein, which is leading the market as we speak. Over FY26 this year, we have seen unprecedented volatility in prices, and also last year, what the market expects from our peer group, global CPGs, and protein suppliers is that food manufacturers shift their strategies. They expect that food manufacturers reduce WPC and WPI. Whey isolate and concentrate content and reformulate the products towards alternatives because of the high input costs. And this has actually led to the elevated price points of these alternatives, which we are seeing in milk protein concentrates, for example. Of course, alternative protein substitutes and ingredients are coming to the market, which may have disadvantages in solubility, taste, and texture, but Solein as an ingredient offers a durable opportunity for these customers and their consumers through reformulation based on functionality, economics, and supply independence. And I would like to also highlight that regardless of this unprecedented volatility and high prices, our business case and investment case on the long-term horizon is not dependent on these ingredients' pricing at all. A little bit of what we see in the European markets. Some of the highlights. A snapshot of what has been happening over the past four years is shown here. Protein is everywhere; like I said, protein is coming into almost every single category and application. And this is becoming an industry-wide shift, not just a consumer frenzy and a short-term trend. The fastest-growing launch categories have actually been bars, ready-to-drink beverages, and protein ice creams, in which the company, Solar Foods, has been investing heavily over the past years. As we identified in our 2024 strategy update during the Capital Markets Day in December, we hit the nail on the head regarding the selection of these categories, and we see that the competitive landscape provides us with quite a bit of tailwind. We see a trend. Of course there are launches, but on top of this, major food companies are committing more and more R&D resources, bringing more capacity on stream, as well as committing to interesting M&A transactions in the field. And these launches are referring to them. Again, these show commitment to this experimentation and exactly underline the fact that consumer trends and willingness to try these are increasing, not necessarily that sell-through or repeat purchases are on their agenda while they move on. But we, of course, expect that some products may fail. Protein washing is indeed a trend that is being underscored and underlined in the markets at the moment. But we believe with this ingredient, customers can really add more value on a global perspective and wider perspective on these categories, and how Solein behaves is that it really offers a unique value proposition in other categories as well. Our multi-year collaboration with our customers proves that Solein indeed excels. In a number of these key categories, such as RTDs, ice cream, baked goods, bars, and ready-to-mix shakes. By the way, we see that Solein offers a durable opportunity for customers through reformulation. It is a very versatile ingredient. We have strong results in UHT-treated products like ready-to-drink beverages developed with our partners over our multi-year development journeys. We also see interesting heat durability and improved extrusion capabilities, as well as improved digestibility of the ingredient, which is at the very core of these ingredients. I want to underscore its importance. The meaning and importance of clean labeling alongside this nutrient density. It is becoming more and more important to have clean-label and less-processed foods for the end consumers, which might also challenge those protein-fortified products based on animal ingredients. I want to take an example from the first half of this year and over the summer, which continued into the second half of the year: the launch with Ambrosia Collective, which came online in May this year. It has basically become their bestseller on their online platform and in their online channels, including Amazon and their own website. And we are expecting to see more and more flavors. Recently, they announced the melted chocolate flavor and are together with us aiming for a US-wide distribution with this product. So a lot of interesting stuff is in the pipeline, meaning that our investment in the product is really starting to pay off. Of course, I want to make a note on a very important theme in the food markets at the moment, which is GLP-1, which Rami already introduced. We want to highlight a couple of key parameters: of course, people are shifting towards healthier lifestyles, and this also includes medication like GLP-1; for us, it means greater nutrient density per calorie, which Solein provides. We see that protecting muscle mass during weight loss is becoming more and more vital. And on top of the high protein content, patients on GLP-1 are looking for more fiber and fiber intake on a daily basis, and I want to highlight that. Of course, Solein's fiber content, about 40% of which is beta-glucans, has a super strong value proposition in the GLP-1 space. A little bit about the numbers. We are going to see a massive shift towards higher intake and penetration of GLP-1 treatments by 2030. We are expecting about 70 million consumers, combining Europe and the US, being under GLP-1 treatment. And in the adult population. This could actually mean a potential incremental increase in protein demand of about 250 kilotonnes per year. This introduces a massive opportunity for Solar Foods, and I want to highlight that whenever people shift towards GLP-1, publicly available market data shows that three main categories are seeing increasing volumes: yogurt and yogurt drinks, meat snacks, and nutrition bars, including protein bars, in which the company has invested significantly over the years, and the first products are going to be seen relatively soon. All right. A little bit about our go-to-market strategy and what is happening next. As I said. The go-to-market strategy technically remains the same. As you know, we have been focusing on a quick go-to-market strategy with fast-moving, agile health and performance companies, especially in the United States and Europe, and also focusing on large CPGs, on the partnerships and long-term demand for Factory 02 volumes, for which we have already had quite interesting results. Now we add another market, the European Union, where the regulatory risk has been substantially reduced; customer discussions are advancing, and commercial preparations are now accelerating towards the final investment decision of the next factory, so let's discuss a little bit more about the European Union and go-to-market activities. We continue to target CPGs, food ingredient distributors, and health and performance brands, as well as selected fast movers. We continue to build the initial sales pipeline and expect the first launch of this product next year. Several major food brands in Europe and health and performance brands are now clear to proceed with their concept and recipe development, and most likely are going to provide launch plans in more detail as we move forward with this plan. But now one of these partners and customers that has been with us as a shareholder, and on board for many years, is here today with us, Fazer Group. A very well-established Finnish Nordic CPG company is now here today with us and their representative. Heli Anttila, Vice President of Product Development, Innovation and Public Affairs, is here with us today. Heli, you have already joined the stage. Welcome again and over to you.
Thank you very much. I am happy to be here. And congratulations on the really significant milestone in the journey. So a few words about how we are preparing the launch of Solein into consumer products in Europe. The decisions made this decade will have a long-lasting impact on our future. At Fazer, our mission is to create food with a purpose. We aim to create long-term value while mitigating climate change and operating within planetary boundaries. At the same time, consumers are looking for products that support their health, well-being and more sustainable lifestyles. Meeting these challenges requires new innovations, new sources of nutrition, and new products for consumers. This is why Fazer and Solar Foods entered into a strategic partnership in 2019. Together, we have been developing and commercializing Solein, a novel protein ingredient that can complement existing protein solutions for the consumers. Fazer is one of Solar Foods' first commercial partners. It is the largest shareholder and has also been involved in the development of this Finnish pioneering innovation from the very beginning. The partnership combines expertise in R&D, innovation, and commercialization to help shape more sustainable food systems for the future. We have been. Fazer has been the first company in the world to bring Solein into packed consumer products. So we have discussed the idea together already in 2021. Then the Singapore pilot was launched when the Singapore novel food approval was granted in 2023 under the Taste the Future concept. It is an umbrella concept. While piloting, we are prototyping and branding alternatives for these new novel ingredients for the consumers. Then Solar Foods received US approval for the Solein protein. We piloted in the US in 2025, combining Fazer's chocolate and oat expertise with Solein protein. And now, we are approaching the European Commission approval next year. So we have been preparing the readiness to launch in Europe. Key learnings from these pilots. Of course, we conduct pilots to learn from consumers about the novel ingredient and our new innovations. It needs to be easy to understand. So communication is key for consumers. People tend to expect that the product tastes a little bit weird or something different if they do not fully understand what it is. It is important that it is part of a familiar product format that is easier for consumers to test and subsequently incorporate into their daily use. Taste is always key when we talk about food products, and when it is a familiar product that tastes great, consumers are truly interested in the product. The feedback we received from the first pilot was that it felt a little unusual to consider food produced literally out of thin air. But then they realized that they really loved the product, noting that the taste is excellent and good. They also thought that it is a really innovative product. Is it really good? But when they tasted it, they saw that it was extremely good, and there were many questions about when it would be available after the pilots. So that is coming next. So we are preparing to launch Solein consumer products in Europe. We are ready to bring the Solein-containing consumer products to the European market once. Then the final approval is granted by the European Commission. As we heard earlier, interest in the protein continues to increase and our aim is to make this high-protein innovation easily available for consumers by bringing them Solein in familiar product types and solutions. Solein brings something very new into the already crowded protein category, and I think successful commercialization is key, bringing innovations like Solein to a larger audience and creating a real impact for the consumers. So this is the plan. And thank you very much for the great cooperation with the Solar Foods team and congratulations on the significant milestone.
Yeah, likewise. Thank you for the absolutely great collaboration. And we are also shareholders of the company as well. Actually, it has been a good collaboration in R&D. This would not be possible. Let's make a good plan. A successful launch after the European authorization is imminent. All right. So, I will now summarize this significant day. Here is what we have today. So, what you actually need to understand before we go is the best way to invest in Solar Foods. Now, if we take a step back, I mentioned that the United Nations faces a challenge at the moment to produce enough food for 2050 and the coming years. Providing sufficient, nutritious food for all people on the planet. I also commented that there are different solutions. There are different solutions. Agriculture. You can continue. Perhaps more. We can use digital AI to try to do it better. But land availability is no longer sufficient. It is very limited what you can do. And then, based on all the analyses, it is now seen by multiple countries that. Fermentation technology is the leading technology that enables the decoupling of food production from agriculture, and gas fermentation is at the forefront. What I mentioned is the leading technology to make it at high volumes and at affordable prices as well. Today in gas fermentation for food production, there is only one company that has permission to sell in any country: Singapore and the US. It is Solar Foods. Now we are really on a journey to start towards Europe and make European consumers and customers successful together after the EFSA approval. Finally, this is possible in Europe as well. So we have more than 200 patents supporting our gas fermentation process. We are the leading pioneering technology company for that. Where we are today, we are in commercialization and scaling, and we are absolutely able to scale with our partners, with our go-to-market partners, CPG companies, and health and performance companies. We are also building factories with our technology partners. So everything is in place, and we are waiting for our home market to finally open soon. All right. So this is the big picture, perhaps just one more time. What we typically like to say is why? Why do we invest in Solar Foods in light of the megatrends? We are in the sweet spot and the only company connecting the megatrends of protein, food sovereignty, as well as the energy transition, where we use hydrogen as one of the key raw materials to capture CO2. So what does this mean in the near term? Perhaps you are interested in this slide here. So this positive EFSA opinion. It will advance all our negotiations with our customers. What have they actually been waiting for? Is this now happening for our customers or not? And now you have already heard that we have doubled our addressable market. So we gain more supporting pillars. The two main markets, which are now the US and Europe, are expected to support our business. So this is absolutely great. As CEO, on behalf of Solar Foods, I can say that this is a bright future. Number two, you have already heard about our unique value propositions. Over these years, we have been working with our customers and collaboration partners, like Fazer, as you heard. And this provides feedback for us on what works, what does not work, and how we can actually bring the next generation of Solein to our consumers as well. And we are absolutely great at producing high-quality protein. How about quality protein? We also have fibers as Ilkka Saura was explaining. And of course, we have high-quality minerals and vitamins as well. In the US and Singapore, you can find Solein-based products, and we are really counting the days or months until next year, summertime, assuming everything goes according to our expectations. So we are launching that together with our partner Fazer here as well. And I believe there will be many more customers who are eager to work with us as well. So big launches you can expect. You saw the whole map earlier, confirming that the European market is expected to open. This is the key milestone. The EFSA scientific opinion is a key milestone for food safety. And then if we go to number four, this is enabling and de-risking all our financial plans and how we collect the final part of the funding for our Factory 02 project. And, of course, the offtake agreements, which we need in order to make the final investment decision. So, this is absolutely key. And then you can see that perhaps it took a little bit longer with EFSA than we expected. This took more than five years. So, of course, we are adjusting all our plans now. This is now the time to continue accelerating this. And of course, we are reviewing how the final investment decision for Factory 02 and the negotiations with our offtake customers in Europe will now proceed. So that is the key moment. To summarize, three things happened today. Solein is seen as safe in Europe by the EFSA, the food authority. We doubled our market, which is very good for our business, and also de-risking this, ensuring that we could get enough offtakes for Factory 02, and number three. Now we are really accelerating our negotiations with our customers and our offtakers for Factory 02. I am very happy for today because not only Ilkka and I, but you and Maria have also been waiting for this. I know that there has been heavy, hard work over multiple years by our regulatory affairs team, as well as all our partners supporting that as well. And the whole Solar Foods team worked to make this day happen. We have ended up with very positive news and I am very, very happy. And thank you for that. And looking forward to what more we can do together now with our partners with this new information. So next, I think we will move to Q&A. What about if you come back here and we start to take some questions?
Yes. Thank you. We have received a couple of kind messages saying congratulations. So thank you very much for those. Rami, let's start with you. Can you tell us more about the novel food regulatory process in the EU? What makes this opinion a major milestone for the company?
Perhaps I will refer a little bit to what I explained. EFSA is seen as the gold standard globally for any of those scientific safety assessments. So when EFSA gave their outcome, it was positive news. So, of course, this is a major milestone for Europe. Very good. We can accelerate all our negotiations with customers and towards the final investment decision, but it will also help with other countries. Many countries follow what EFSA decides because they know that EFSA performs very extensive, thorough analyses, and we need to have scientific evidence that this is a safe product, a safe production process, and that the daily consumer intake aligns with the categories for which we have applied. This is a major milestone for us, and I am especially glad that European consumers and those in our home market can, I hope, very soon enjoy Solein-based products.
Thank you. Rami, are you expecting new companies to join Factory 02 offtake negotiations now that you have received the positive EFSA opinion? Or should we assume you will progress for now solely with the ones already under LOI?
Yeah. So if we take a perspective, for example, of a European health and performance brand, their progress in bringing Solein as one of their ingredients in the product range has been somewhat constrained because of this regulatory process. Now, today showed that, yes, indeed, in certain selected strategic categories, this will become, as per the company's expectations, possible in the very near, foreseeable future. Feedback. What we have received from these kinds of customers is that some are willing to progress and have been willing to progress regardless of the status, but now we expect acceleration in the pipeline both in terms of new logos and in accelerating the existing ones towards binding deals.
Thank you. Ilkka, another question for you. Go ahead. You mentioned in the press release that EFSA opinion means Solein is safe to use as a protein ingredient in selected strategic food categories. How broad are these selected strategic food categories? Is there a reason to assume Solein-allowed applications will be more narrow at first in Europe and broaden later on?
Yeah. Indeed, this safety assessment is based on a wide and extensive statistical analysis of different intake food categories across age groups. Our assessment has been completed, and the categories included in the statistical datasets and part of EFSA's assessment are there. However, I want to highlight that the categories will be finally approved by the European Commission and remain to be worked on by the company and the Commission itself. So the ones that we have mentioned in the opinion are not necessarily final and are something that we continue to evaluate. The focus on the categories will certainly be the categories which we have said publicly. So health and performance, the fastest growing categories like bars, drinks, protein ice creams, and similar products. It remains to be seen what the final categories will be. And we will certainly keep you updated about that.
Thank you. Ilkka. Then a couple of questions about Factory 02 for Rami. Does the EFSA conclusion have any importance for the Lappeenranta factory investment decision? And does Solar Foods still aim to make the final investment decision on Factory 02 in 2026?
This is a huge impact. Many of our European customers. We have been working on this for multiple years. You have heard that already. They have been working together with us for many years. But then there are other big companies as well, especially in Central Europe. And then it is as Ilkka Saura said. So, some have been proactive and leaned forward, saying that we will eventually get this EFSA scientific opinion—a positive opinion—and they do not want to lose any time for their launches, and perhaps help in their supply chain, price points, and quality as well. As we commented. This is now de-risking and unlocking this situation, especially with the European customers. And now I see that together with our team, Ilkka, and a few others, we can accelerate the discussions. We have been paused and waiting for this moment for quite a few months, to be frank. And now those discussions are accelerating. Then with those discussions, we will get enough offtakes. Of course, the US market is open. We are having similar discussions over there. Then we have enough to ensure the funding that we need with the terms. What are multi-year? The terms are, of course. And then that will be leading us to the final investment decision of the Factory 02. I would also like to highlight that we continue to work very closely with our technology partners, Fortum and GEA, who are our key partners in building the blueprint of Factory 02. And this is also one of the key elements. In order to have a factory clearly designed. And when we have offtakes and funding, that is helpful. Then the final investment decision will happen.
Thank you, Rami. We have time for a couple more questions. Elke, can Solein powder be heated, or will the bacteria die?
Of course, it goes through a thorough downstream processing at our factory. Regarding heat stability, it is robust. First of all, there is full pasteurization, homogenization, drying, and multiple other steps. It is already a stable and processed ingredient as such. But what we are seeing, for example, in the baked goods category, is that Solein can indeed replace some of the animal-based and plant-based ingredients in applications, even through heating, while providing certain value adds. So it is indeed capable of handling heat relatively well.
Thank you. A final question for Rami. Please estimate your moat from now on.
Great question. So this could be another chapter to tell. But if I may briefly reiterate what I have said. The big picture. We are the leading pioneering technology company platform, and we are now building an ecosystem around it because that makes us much stronger to establish not just one or two, but multiple factories. Demand is there; demand is there. There is no other gas fermentation company that has permission for human food anywhere on Earth. So we have Singapore and the US authorization to sell at the moment, and we are currently going through the regulatory process in other markets as well. So we are the leading company there now. This is a journey. Clearly, the outlook is very positive for Europe as well. We have more than 200 patents protecting our process. We have our own microbe as well. What we have not published yet, either. So it's in our hands. So I see that this is absolutely key moat for us together with our Solein product value propositions. So if you think about it, we have this dual processing platform, and then we have the product, which is excellent as well, in taste, texture, and all the other value propositions. So I am very confident with our moat. So the future is bright for us.
Thank you. And thank you, Ilkka. This concludes our webcast today. Thank you everybody in the audience for joining, and see you next time. Have a great day.
Thank you.
Thank you.



















